Compare CVKD & STAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVKD | STAI |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7M | 24.6M |
| IPO Year | 2023 | N/A |
| Metric | CVKD | STAI |
|---|---|---|
| Price | $7.41 | $2.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | 81.7K | ★ 180.1K |
| Earning Date | 11-10-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,881,045.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 260.24 |
| 52 Week Low | $6.75 | $2.82 |
| 52 Week High | $22.90 | $243.80 |
| Indicator | CVKD | STAI |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 64.92 |
| Support Level | $6.75 | $3.10 |
| Resistance Level | $7.75 | $4.15 |
| Average True Range (ATR) | 0.96 | 0.40 |
| MACD | -0.18 | 0.21 |
| Stochastic Oscillator | 12.87 | 61.18 |
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.